Tavneos: Shocking Deaths Exposed!

FDA links Amgen's Tavneos to liver injuries and deaths, raising serious questions about patient safety. What did Amgen know?

FDA Issues Urgent Warning

The FDA confirms Tavneos, used to treat ANCA-associated vasculitis, is connected to severe liver damage and fatal outcomes. Details are emerging.

Deadly Link Confirmed: Who Knew?

The FDA's investigation revealed a direct correlation between Tavneos and life-threatening liver issues. The exact number of deaths remains undisclosed...

Patients 'Betrayed' by Drug?

Sources reveal patients were not fully informed of Tavneos' potential liver risks. Was informed consent truly obtained by doctors?

Victim's Family Speaks Out!

"We trusted this drug would help, not kill," says the devastated spouse of a Tavneos patient. Lawsuits are expected, fast.

Amgen Silenced on Side Effects?

Insiders claim Amgen downplayed liver injury reports during Tavneos' clinical trials. The truth about the drug's risk is emerging.

The Truth About Liver Failure

Records show a significantly higher rate of liver failure among Tavneos users compared to other treatments. Nobody expected this outcome.

Cover-Up Allegations Emerge!

Documents leaked online suggest Amgen attempted to bury negative Tavneos data. Could this now trigger a criminal investigation?

Tavneos Facing an Imminent BAN?

Pressure mounts as calls for Tavneos to be immediately withdrawn intensify. The drug's future hangs by a thread. The world is watching.

Bombshell Lawsuit Filed!

A massive class-action lawsuit against Amgen is imminent, potentially bankrupting the pharmaceutical giant. What happens to Tavneos patients now?